High Prevalence of Multidrug Resistant Bacteria in Cirrhotic Patients with Spontaneous Bacterial Peritonitis: Is It Time to Change the Standard Antimicrobial Approach?

Table 2

Bacterial resistances of most prevalent germs against specific antibiotics among all cultures.

Microorganism	Acinetobacter; (n=6)	E. coli; (n=49)	Enterobacter; (n=7)	Enterococcus; (n=23)	Klebsiella pneumoniae; (n=27)	S. aureus; (n=31)	Pseudomonas sp.; (n=4)	Coag-negative Staphylococcus; (n=19)	All germs; (n = 183)
Resistance category (%)
MDR	33,3%	53,1%	28,6%	17,4%	18,5%	38,7%	---	47,4%	32,2%
XDR	50,0%	12,2%	14,3%	0,0%	22,2%	9,7%	---	0,0%	10,3%
Specific resistances (%)							---
Oxacillin	---	---	---	---	---	45,2%	0,0%	42,1%	12,0%
Vancomycin	---	---	---	17,4%	---	---	0,0%	5,3%	2,7%
Clindamycin	---	---	---	---	---	64,5%	---	42,1%	15,8%
Gentamycin	66,7%	14,3%	0,0%	4,3%	25,9%	41,9%	---	36,8%	21,9%
Amicacin	100,0%	2,0%	0,0%	---	3,7%	---	25,0%	-	5,5%
Ampicillin	---	69,4%	---	34,8%	---	---	---	-	24,0%
Ampicillin-Sulbactam	66,7%	34,7%	57,1%	---	44,4%	---	0,0%	-	26,8%
Piperacillin-Tazobactam	100,0%	4,1%	14,3%	---	33,3%	---	25,0%	-	13,1%
Cefuroxime	---	24,5%	42,9%	---	40,7%	---	0,0%	-	23,5%
Cefotaxime	---	10,2%	0,0%	---	25,9%	---	25,0%	-	8,7%
Ceftazidime	100,0%	12,2%	0,0%	---	37,0%	---	0,0%	-	14,8%
Ceftriaxone	100,0%	22,4%	28,6%	100,0%	37,0%	45,2%	0,0%	0,0%	39,3%
4th gen.cephalosporin	100,0%	14,3%	0,0%	---	40,7%	---	0,0%	-	14,8%
Levofloxacin/Ciprofloxacin	100,0%	36,7%	14,3%	17,4%	25,9%	35,5%	---	26,3%	30,1%
Imipenem	---	2,0%	0,0%	0,0%	7,4%	---	---	-	1,6%
Meropenem	100,0%	0,0%	0,0%	---	14,8%	---	---	-	5,5%
Trimethoprim-Sulfamethoxazole	83,3%	61,2%	14,3%	---	37,0%	12,9%	---	26,3%	31,7%